Crossmark Global Holdings Inc. decreased its stake in shares of Aetna Inc (NYSE:AET) by 11.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 36,033 shares of the company’s stock after selling 4,838 shares during the period. Crossmark Global Holdings Inc.’s holdings in Aetna were worth $6,500,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. National Asset Management Inc. lifted its position in Aetna by 4.3% during the 2nd quarter. National Asset Management Inc. now owns 2,859 shares of the company’s stock worth $436,000 after buying an additional 119 shares in the last quarter. Cypress Capital Group lifted its position in Aetna by 5.3% during the 2nd quarter. Cypress Capital Group now owns 4,482 shares of the company’s stock worth $681,000 after buying an additional 225 shares in the last quarter. Advisory Services Network LLC lifted its position in Aetna by 16.2% during the 2nd quarter. Advisory Services Network LLC now owns 1,780 shares of the company’s stock worth $270,000 after buying an additional 248 shares in the last quarter. Hartford Investment Management Co. lifted its position in Aetna by 0.4% during the 3rd quarter. Hartford Investment Management Co. now owns 79,409 shares of the company’s stock worth $12,627,000 after buying an additional 291 shares in the last quarter. Finally, Violich Capital Management Inc. lifted its position in Aetna by 0.4% during the 3rd quarter. Violich Capital Management Inc. now owns 70,375 shares of the company’s stock worth $11,190,000 after buying an additional 299 shares in the last quarter. Institutional investors and hedge funds own 87.10% of the company’s stock.
Shares of Aetna Inc (NYSE AET) traded down $0.97 during mid-day trading on Wednesday, hitting $177.55. The stock had a trading volume of 828,496 shares, compared to its average volume of 2,901,128. The company has a current ratio of 1.68, a quick ratio of 0.53 and a debt-to-equity ratio of 0.52. The company has a market cap of $57,993.06, a PE ratio of 31.00, a PEG ratio of 1.44 and a beta of 0.60. Aetna Inc has a one year low of $124.83 and a one year high of $194.40.
Aetna (NYSE:AET) last announced its quarterly earnings results on Tuesday, January 30th. The company reported $1.25 EPS for the quarter, beating analysts’ consensus estimates of $1.18 by $0.07. The company had revenue of $14.74 billion during the quarter, compared to analysts’ expectations of $14.79 billion. Aetna had a return on equity of 21.50% and a net margin of 3.15%. Aetna’s revenue was down 6.2% on a year-over-year basis. During the same period in the prior year, the business posted $0.08 EPS. analysts anticipate that Aetna Inc will post 10.99 EPS for the current year.
The business also recently declared a quarterly dividend, which was paid on Friday, January 26th. Stockholders of record on Thursday, January 11th were paid a $0.50 dividend. The ex-dividend date of this dividend was Wednesday, January 10th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.13%. Aetna’s dividend payout ratio (DPR) is presently 34.78%.
A number of research firms have issued reports on AET. Piper Jaffray Companies upgraded shares of Aetna from a “neutral” rating to an “overweight” rating and set a $136.00 target price on the stock in a research report on Wednesday, January 3rd. Wells Fargo & Co restated an “outperform” rating and set a $208.00 target price (up from $200.00) on shares of Aetna in a research report on Monday, December 4th. Morgan Stanley downgraded shares of Aetna from an “overweight” rating to an “equal weight” rating and set a $179.00 target price on the stock. in a research report on Wednesday, December 20th. Deutsche Bank upgraded shares of Aetna from a “hold” rating to a “buy” rating and upped their target price for the company from $195.00 to $212.00 in a research report on Monday, January 22nd. Finally, ValuEngine upgraded shares of Aetna from a “hold” rating to a “buy” rating in a research report on Sunday, December 31st. Ten equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. The company has an average rating of “Buy” and an average price target of $185.94.
TRADEMARK VIOLATION NOTICE: This news story was originally published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this news story on another site, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright legislation. The legal version of this news story can be accessed at https://www.dispatchtribunal.com/2018/02/14/aetna-inc-aet-shares-sold-by-crossmark-global-holdings-inc.html.
Aetna Company Profile
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.